Cd3 antibody biolegend il6
Por um escritor misterioso
Descrição
Engineering Bifunctional Antibodies with Constant Region Fusion Architectures
IL-6 trans-signaling in a humanized mouse model of scleroderma
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies - Nouveau - 2021 - European Journal of Immunology - Wiley Online Library
Cells, Free Full-Text
iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis - Cytotherapy
Anti Dog CD3 Antibody, clone CA17.2A12
IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling
Engineered bispecific antibodies targeting the interleukin-6 and -8 receptors potently inhibit cancer cell migration and tumor metastasis: Molecular Therapy
Life, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)